Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
RENINAAV Dose-Dependently Exacerbate Albumninuria and Glomerulosclerosis, and Reduce GFR in Female Uninephrectomized DB/DB Mice

Mette Viberg Østergaard1, Rune Ida1, Annemarie Aarup Pedersen,Thomas Secher, Frederikke Emilie Sembach, Sebastian Tølbøl Thrane, Urmas Roostalu, Keld Fosgerau, Lisbeth N Fink, Niels Vrang, "Dose Escalating Toxicology Study of ELP-VEGF, a Novel Biologic for Renal Therapeutic Angiogenesis," ERA-EDTA Meeting 2020, Nephrology Dialysis Transplantation 35 (Supplement 3):P0990.